AFib or AF patients of less than 48 hours duration with CHA2DS2-VASc score of ≥2 in men and ≥3 in women can be administered heparin, FXa inhibitor, or direct thrombin inhibitor as soon as possible before cardioversion, followed by long-term anticoagulation therapy. The gene discussed is F10; the disease is atrial fibrillation.